SCHEMBL24201079

SCHEMBL24201079

OCCOCCOCCOC12CC3CC4CC(C1)C2(C4)C3

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24201097 1.00 MEN1 (0.33) MEN1KMT2ATSHRMAPK1
SCHEMBL24201347 1.00 MEN1 (0.33) MEN1KMT2ATSHRMAPK1
SCHEMBL24201267 0.91 ALOX5AP (0.31)
SCHEMBL24201130 0.83 EPHX2 (0.33)
SCHEMBL24201269 0.83 EPHX2 (0.33)
SCHEMBL24201089 0.81 EPHX2 (0.34)
SCHEMBL24201283 0.81 OPRK1 (0.30)
SCHEMBL24201152 0.81 OPRK1 (0.30)
SCHEMBL24201080 0.80 EPHX2 (0.37)
SCHEMBL24201254 0.80 EPHX2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3618833-B1 TRIPARTITE ANDROGEN RECEPTOR ELIMINATORS, METHODS AND USES THEREOF SPG THERAPEUTICS INC (US) 2022-01-19 EP disclosed